ZELUMA

Serial Number 77162728
606

Registration Progress

Application Filed
Apr 23, 2007
Under Examination
Feb 26, 2008
Approved for Publication
Nov 14, 2007
Published for Opposition
Dec 4, 2007
Registered

Trademark Image

ZELUMA

Basic Information

Serial Number
77162728
Filing Date
April 23, 2007
Published for Opposition
December 4, 2007
Abandonment Date
March 28, 2011
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Mar 28, 2011
Classes
005 010

Rights Holder

Alimera Sciences, Inc.

03
Address
6120 Windward Parkway, Suite 290
Alpharetta, GA 30005

Ownership History

Alimera Sciences, Inc.

Original Applicant
03
Alpharetta, GA

Alimera Sciences, Inc.

Owner at Publication
03
Alpharetta, GA

Legal Representation

Attorney
Bassam N. Ibrahim, B. Parker Livingston, Jr., Fred W. Hathaway, Holly M. Ford, Bryce J. Maynard and Jennifer L. Williston

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

42 events
Date Code Type Description Documents
Jun 5, 2013 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Mar 28, 2011 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Mar 28, 2011 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Nov 15, 2010 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Nov 12, 2010 CORV P REVIEW OF CORRESPONDENCE COMPLETE Loading...
Nov 11, 2010 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Oct 12, 2010 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Oct 8, 2010 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Aug 10, 2010 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 9, 2010 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jul 30, 2010 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 30, 2010 EXT5 S SOU EXTENSION 5 FILED Loading...
Jan 13, 2010 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jan 13, 2010 EX4G S SOU EXTENSION 4 GRANTED Loading...
Nov 20, 2009 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 20, 2009 EXT4 S SOU EXTENSION 4 FILED Loading...
Jul 22, 2009 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jul 21, 2009 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 21, 2009 EXT3 S SOU EXTENSION 3 FILED Loading...
Feb 20, 2009 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 20, 2009 EX2G S SOU EXTENSION 2 GRANTED Loading...
Feb 6, 2009 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 6, 2009 EXT2 S SOU EXTENSION 2 FILED Loading...
Aug 21, 2008 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 21, 2008 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 21, 2008 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 26, 2008 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 4, 2007 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 14, 2007 NPUB O NOTICE OF PUBLICATION Loading...
Oct 29, 2007 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Oct 27, 2007 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 25, 2007 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 25, 2007 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 25, 2007 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 10, 2007 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 10, 2007 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 10, 2007 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 6, 2007 DOCK D ASSIGNED TO EXAMINER Loading...
May 23, 2007 ALIE A ASSIGNED TO LIE Loading...
May 23, 2007 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
May 7, 2007 MAIL I PAPER RECEIVED Loading...
Apr 26, 2007 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of macular edema, macular disease, retinal disease, glaucoma, and occular allegry
First Use Anywhere: 0
First Use in Commerce: 0
Class 010
Sustained drug delivery systems for ocular drugs
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Translation
The wording ZELUMA has no meaning in English.

Classification

International Classes
005 010